Elsevier
  Sign Up Send Feedback Tell a Friend Search Archive View Sample
 
Weekly E-Mail newsletter
For physicians in Internal Medicine, Cardiology, Geriatrics, Women's Health,
and Adolescent Medicine
News from hundreds of top industry sources
It's what clinicians need to know
It's FREE!
   
  About SmartBrief

About The American Journal of Medicine, published by Elsevier

About Elsevier

Visit other Elsevier Health Science publications

Privacy Policy
   
Send AJMPlus story to a colleague.

* Your Name
* Your E-mail
* Friend's E-mail
Separate multiple addresses with commas.
  Personal Message
* Indicates required fields
Terms and Conditions: You must submit valid e-mail addresses only. Use of e-mail addresses is subject to the terms of SmartBrief's privacy policy.
Here's the story you're sending:
Efficacy of statins in the elderly
Many patients ?80 years of age receive statin therapy for primary prevention and are treated to aggressive low-density lipoprotein levels. Since efficacy is uncertain and potential adverse effects are many, we urgently need to define the cost, benefit and risk of statin use in the very elderly.  American Journal of Cardiology, The (11/15)